Skip to main content
OpenTrials
Completed

NCT Number: NCT00966394

Salivary Bacteria and Oral Health Status in Children With ADHD

Attention deficit and hyperactivity (ADHD) affect 6% of school-aged children. Few studies reported higher prevalence of caries and restorations among children with ADHD. Methylphenidate is the drug of choice to treat ADHD. according to the medical literature methylphenidate can cause xerostomia.

Our study will investigate saliva parameters (such as quantity, bacteria in saliva, buffer capacity), oral hygiene and diet habits and their influence on caries among children with ADHD and among healthy children.

Our hypothesis is:

* Children with ADHD will have more caries. * Children with ADHD will have more detrimental oral hygiene and diet habits. * There will be a difference in the saliva parameters between children with ADHD and healthy children.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • test group- diagnosis of ADHD.
  • control group- ASA1

Exclusion criteria

  • control group
  • administration of medicine at the time of the check-up.

Sponsors and collaborators

Lead sponsor

Hadassah Medical Organization

Other

Registry information

Official study title

Changes in Salivary Bacteria and Oral Health Status in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Acronym: ADHD

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Aug 26, 2009
Registry last updated
May 26, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.